[HTML][HTML] The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
…, G Pruneri, S Wienert, G Van den Eynden… - Annals of oncology, 2015 - Elsevier
Evidence is strengthening for the morphological evaluation of tumor infiltrating lymphocytes (TILs)
in breast cancer. Herein, the concepts for TILs assessment are laid out by pathologists …
in breast cancer. Herein, the concepts for TILs assessment are laid out by pathologists …
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno …
…, M Preusser, J Hainfellner, G Pruneri… - Advances in anatomic …, 2017 - journals.lww.com
Assessment of the immune response to tumors is growing in importance as the prognostic
implications of this response are increasingly recognized, and as immunotherapies are …
implications of this response are increasingly recognized, and as immunotherapies are …
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international …
…, M Preusser, J Hainfellner, G Pruneri… - Advances in anatomic …, 2017 - journals.lww.com
Assessment of tumor-infiltrating lymphocytes (TILs) in histopathologic specimens can provide
important prognostic information in diverse solid tumor types, and may also be of value in …
important prognostic information in diverse solid tumor types, and may also be of value in …
[HTML][HTML] Multidisciplinary meeting on male breast cancer: summary and research recommendations
…, Z Nahleh, J Bergh, B Cutuli, G Pruneri… - Journal of clinical …, 2010 - ncbi.nlm.nih.gov
Male breast cancer is a rare disease, accounting for less than 1% of all breast cancer diagnoses
worldwide. Most data on male breast cancer comes from small single-institution studies, …
worldwide. Most data on male breast cancer comes from small single-institution studies, …
Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
…, G Pruneri, A Goldhirsch, G Martinelli… - Blood, The Journal …, 2001 - ashpublications.org
Circulating endothelial cells (CECs) were enumerated in 20 healthy controls and 76 newly
diagnosed cancer patients by means of 4-color flow cytometry. In breast cancer (n = 46) and …
diagnosed cancer patients by means of 4-color flow cytometry. In breast cancer (n = 46) and …
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment
M Colleoni, G Viale, D Zahrieh, G Pruneri… - Clinical Cancer …, 2004 - AACR
Purpose: The purpose of this research was to identify factors predicting response to
preoperative chemotherapy. Experimental Design: In a large volume laboratory using standard …
preoperative chemotherapy. Experimental Design: In a large volume laboratory using standard …
[HTML][HTML] Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers
Purpose The aim of the current study was to conduct a pooled analysis of studies that have
investigated the prognostic value of tumor-infiltrating lymphocytes (TILs) in early-stage triple …
investigated the prognostic value of tumor-infiltrating lymphocytes (TILs) in early-stage triple …
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised …
…, S Andrighetto, P Dell'Orto, G Renne, G Pruneri… - The Lancet …, 2018 - thelancet.com
Background We previously reported the 5-year results of the phase 3 IBCSG 23-01 trial
comparing disease-free survival in patients with breast cancer with one or more micrometastatic (…
comparing disease-free survival in patients with breast cancer with one or more micrometastatic (…
Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type
…, M Ponzoni, E Pedrinis, S Dell'Oro, G Pruneri… - Blood, 2003 - ashpublications.org
The clinical activity of rituximab has been evaluated in a phase 2 study in both untreated and
relapsed mucosa-associated lymphoid tissue (MALT) lymphomas. Treatment consisted of 4 …
relapsed mucosa-associated lymphoid tissue (MALT) lymphomas. Treatment consisted of 4 …
Antibody–Fc/FcR interaction on macrophages as a mechanism for hyperprogressive disease in non–small cell lung cancer subsequent to PD-1/PD-L1 blockade
…, V Huber, M Milione, L Porcu, C Proto, G Pruneri… - Clinical Cancer …, 2019 - AACR
… G, Representative IHC images of mouse iliac lymph nodes showing tumor cell dissemination
with the presence of a metastatic nodule (indicated by the asterisk) only in nivolumab-…
with the presence of a metastatic nodule (indicated by the asterisk) only in nivolumab-…